Universitat Autònoma de Barcelona-ko ikertzaileekin lankidetzan egindako argitalpenak (11)

2023

  1. Cortical Lewy body injections induce long-distance pathogenic alterations in the non-human primate brain

    npj Parkinson's Disease, Vol. 9, Núm. 1

2022

  1. Brain injections of glial cytoplasmic inclusions induce a multiple system atrophy-like pathology

    Brain, Vol. 145, Núm. 3, pp. 1001-1017

2020

  1. Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primates

    Brain : a journal of neurology, Vol. 143, Núm. 5, pp. 1462-1475

  2. Identification of distinct pathological signatures induced by patient-derived α-synuclein structures in nonhuman primates

    Science advances, Vol. 6, Núm. 20, pp. eaaz9165

2019

  1. Study of the effect of anti-rhGAA antibodies at low and intermediate titers in late onset Pompe patients treated with ERT

    Molecular Genetics and Metabolism, Vol. 128, Núm. 1-2, pp. 129-136

2018

  1. Quantitative muscle MRI to follow up late onset Pompe patients: A prospective study

    Scientific Reports, Vol. 8, Núm. 1

2016

  1. Muscle MRI findings in childhood/adult onset pompe disease correlate with muscle function

    PLoS ONE, Vol. 11, Núm. 10

2012

  1. Effects of surgery and/or remifentanil administration on the expression of pERK1/2, c-Fos and dynorphin in the dorsal root ganglia in mice

    Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 385, Núm. 4, pp. 397-409

  2. Trunk muscle involvement in late-onset Pompe disease: Study of thirty patients

    Neuromuscular Disorders, Vol. 22, Núm. SUPPL. 2

2010

  1. Increased spinal dynorphin levels and phospho-extracellular signal-regulated kinases 1 and 2 and c-Fos immunoreactivity after surgery under remifentanil anesthesia in mice

    Molecular Pharmacology, Vol. 77, Núm. 2, pp. 185-194

2009

  1. Prevalencia de enfermedad arterial periférica asintomática en pacientes con ictus isquémico no cardioembólico

    Neurologia, Vol. 24, Núm. 6, pp. 366-372